Clinical oncology panels
GALEAS™ Bladder
Redefine bladder cancer detection with GALEAS™ Bladder, a comprehensive sample-to-report solution utilizing ultra-sensitive NGS technology.
From a simple urine sample, GALEAS Bladder analyzes 451 somatic mutations across all grades and stages, surpassing 90% sensitivity, and empowers urologists to make better decisions from the initial diagnosis to minimal residual disease (MRD) surveillance.
GALEAS™ Tumor
A clinically validated panel designed in parallel with variant calling software for comprehensive genomic profiling of solid tumors. GALEAS Tumor profiles key DNA biomarkers across 519 genes streamlining the detection of SNVs, INDELs, CNVs, TMB and MSI into a single workflow. Cloud-based bioinformatics pipelines enable rapid integration into any laboratory.
GALEAS™ Hereditary Plus
Uncover hereditary cancer risks with GALEAS™ HereditaryPlus, a clinically validated NGS panel offering comprehensive analysis of 146 genes, precise detection of SNVs, indels, and CNVs, and seamless integration with cloud-based software for reliable variant calling and interpretation.
Cancer research panels
Custom Oncology Panels
Customize your NGS oncology panel with the ultra-sensitive Cell3™ Target enrichment system. Convert cfDNA, gDNA, or FFPE DNA into libraries for next-generation sequencing.
Our error suppression technology enables confident mutation calling down to 0.1% VAF and is ideal for rare variant detection in liquid and tissue biopsies.